| BEQAX | VITSX | BEQAX / VITSX | |
| Total Expense Ratio | 0.90 | 0.03 | 3,000% |
| Annual Report Gross Expense Ratio | 0.90 | 0.03 | 3,000% |
| Fund Existence | 29 years | 29 years | - |
| Gain YTD | 6.177 | 8.531 | 72% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 2500 | 5000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 1.88B | 2.31T | 0% |
| Annual Yield % from dividends | 0.30 | 1.01 | 29% |
| Returns for 1 year | 11.14 | 21.50 | 52% |
| Returns for 3 years | 57.16 | 69.71 | 82% |
| Returns for 5 years | 6.98 | 64.26 | 11% |
| Returns for 10 years | 52.30 | 263.49 | 20% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| ARKG | 38.58 | 2.57 | +7.14% |
| ARK Genomic Revolution ETF | |||
| HBDC | 24.74 | N/A | +0.02% |
| Hilton Bdc Corporate Bond ETF | |||
| MNA | 36.41 | -0.04 | -0.10% |
| NYLI Merger Arbitrage ETF | |||
| QQQP | 219.33 | -2.55 | -1.15% |
| Tradr 2X Long Innovation100 QuarterlyETF | |||
| IWDL | 61.72 | -1.13 | -1.79% |
| ETRACS 2x Leveraged US Value Fctr TR ETN | |||